News

The Food and Drug Administration recently announced that Avet Pharmaceuticals Inc. issued a voluntary recall of the antibiotic, tetracycline, specifically, Tetracycline HCl Capsules USP, 250 mg and 500 mg, distributed under the Heritage Pharmaceuticals Inc. label.

The U.S. Customs and Border Protection has launched a webpage to address questions about importing personal protective equipment and other medical products during the COVID-19 pandemic.

The COVID-19 pandemic has created stresses that most health care workers have never experienced, writes Robert Trestman, M.D., of Carilion Clinic in Roanoke, Va., and 2020 chair-elect of AHA’s Behavioral Health Council. Read more about the resources available for front-line workers.

In this AHA blog, Priya Bathija, AHA vice president of strategic initiatives, shares stories of health care heroes stepping up to address the challenge of COVID-19 and ways the public can support them.

In this AHA blog, Priya Bathija, AHA vice president of strategic initiatives, shares stories of health care heroes stepping up to address the challenge of COVID-19 and ways the public can support them.

The Centers for Medicare & Medicaid Services unveiled a new COVID-19 toolkit for state and local health care decision makers seeking to maximize workforce flexibilities.

In response to frequently asked questions, the Centers for Medicare & Medicaid Services encouraged health insurers to relax otherwise applicable utilization management processes, as permitted by state law, to ensure that staff at hospitals, clinics and pharmacies can focus their limited time and resources on care delivery, and patients can receive needed care without delay.

The Health Resources and Services Administration Federal Office of Rural Health Policy today awarded $161.5 million in Coronavirus Aid, Relief and Economic Security Act funding to help rural hospitals and communities respond to the COVID-19 emergency.

Battelle is adding nine processing sites for decontaminating compatible N95 and equivalent respirators for reuse by health care personnel, bringing the total states served to 15 and Washington, D.C.

Due to the COVID-19 emergency, the Centers for Medicare & Medicaid Services will give hospitals until July 1, 2021 to implement admission, discharge and transfer notification requirements once its final rule on interoperability and patient access is published in the May 1 Federal Register.

The Senate approved by voice vote the Paycheck Protection Program and Health Care Enhancement Act – a $484 billion COVID-19 relief package – which includes an additional $75 billion for hospitals, health systems and other health care providers

The AHA is running ads in Axios newsletters to highlight hospitals and health systems efforts in response to COVID-19.

he Centers for Disease Control and Prevention updated its FAQs on COVID-19 laboratory testing and reporting. Topics include accessing laboratory testing, data and reporting, serology testing and ordering supplies.

Clinicians who participate in a clinical trial for a drug or biological product to treat a patient with novel coronavirus may now earn credit in the Merit-based Incentive Payment System, the Centers for Medicare & Medicaid Services announced.

The Bipartisan Policy Center released a new report examining the immense challenges facing the U.S. rural health care system as highlighted by the COVID-19 pandemic.

Hospitals’ already thin margins plunged into the red in March as non-emergency procedures and revenues fell and expenses for staff, supplies and building capacity rose to prepare for a surge in COVID-19 patients, according to a new report by health care consultancy Kaufman Hall.

The Food and Drug Administration authorized the first diagnostic test with a home collection option for COVID-19.

A panel of experts convened by the National Institutes of Health released COVID-19 treatment guidelines for health care providers, which will be updated as new data become available.

The FBI warned today of specific COVID-19-themed email phishing campaigns targeting U.S.-based medical providers.

The Food and Drug Administration said that it will temporarily forgo action against 503A compounding pharmacies that provide to hospitals certain compounded drugs without patient-specific prescriptions.